Related Experiment Video
Updated: Jun 16, 2026
06:25
Ex Vivo Culture of Circulating Tumor Cells in the Cerebral Spinal Fluid from Melanoma Patients to Study Melanoma-Associated Leptomeningeal Disease
Published on: March 29, 2024
GLO1 overexpression in human malignant melanoma
Warner B Bair1, Christopher M Cabello, Koji Uchida
1Department of Pharmacology and Toxicology, College of Pharmacy and Arizona Cancer Center, University of Arizona, Tucson, USA.
Melanoma Research
|January 23, 2010
Summary
Glyoxalase I (GLO1) is upregulated in melanoma, aiding cancer cell defense against cytotoxic methylglyoxal. Blocking GLO1 increases methylglyoxal damage, highlighting its role in melanoma progression.
Area of Science:
- Biochemistry
- Oncology
- Molecular Biology
Background:
- Glyoxalase I (GLO1) detoxifies methylglyoxal, a harmful byproduct of glycolysis.
- GLO1 is implicated in cellular defense against damage in diabetes, cancer, and aging.
- Cancer cells may utilize GLO1 for metabolic adaptation.
Purpose of the Study:
- To investigate GLO1 expression in human melanoma.
- To determine the functional role of GLO1 in melanoma cell defense against methylglyoxal.
Main Methods:
- Quantitative reverse transcription polymerase chain reaction (qRT-PCR) on melanoma tissue arrays.
- Immunohistochemical analysis of melanoma tissue microarrays.
- siRNA interference to knockdown GLO1 expression in melanoma cell lines (A375, G361).
- Proteomics and mass spectrometry to identify methylglyoxal-adducted proteins.
Main Results:
- GLO1 mRNA and protein levels are significantly upregulated in human melanoma tissues compared to healthy controls.
- siGLO1-treated melanoma cells showed increased sensitivity to methylglyoxal-induced cytotoxicity, apoptosis, and oxidative stress.
- Methylglyoxal-adducted heat shock protein 27 (Hsp27) was identified in melanoma cells.
- siGLO1 transfection increased methylglyoxal protein adduction.
Conclusions:
- GLO1 plays a crucial role in protecting melanoma cells against methylglyoxal toxicity.
- Upregulation of GLO1 is a key adaptation in malignant melanoma for methylglyoxal detoxification.
- Targeting GLO1 may represent a therapeutic strategy for melanoma treatment.
Related Concept Videos
01:06Induced Pluripotent Stem Cells
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...
Somatic cells are...
02:23Abnormal Proliferation
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...